The Tumor Center is divided into eleven organ tumor centers. In order to take account of the further development of oncology, these are supplemented by two competence networks, which serve as cross-sectional services. By establishing these two competence networks, our tumor center has entered a new era of oncology in order to guarantee our patients individual, interdisciplinary care based on the latest findings.

The networks interact closely with the individual organ tumor centers and develop guidelines for diagnostics, therapy and side effect management. They serve as a coordination point for clinical and translational research projects and have both established their own tumor board.

The Immunotherapy Board takes place once a month. Here, immunotherapy patients are discussed individually by the specialists from various disciplines involved and therapies are determined. Great care is taken to ensure that the side effects of the therapy are controlled or avoided. In addition, the new immune strategies should be cleverly combined with existing therapeutic approaches in order to achieve maximum effect.

Patients benefit from the constantly updated shared knowledge and clinical expertise, as the therapeutic strategies are continuously adapted to international standards. In close cooperation with the referring physicians in the region, we also strive to participate in innovative studies.

Monday: Prof. Alfred Zippelius
Friday: Dr. Heinz Läubli

Registration
University Hospital Basel
Clinic for Oncology
Petersgraben 4
4031 Basel

Phone +41 61 265 50 74 and +41 61 265 50 59
onkologie@usb.ch

Management

711ab237-1769-4f1c-a5a8-de6344d45e56

Prof. Heinz Läubli

Leitender Arzt / Leitung Klinische Forschung

medizinische Onkologie FMH, allgemeine Innere Medizin FMH, Mitglied Tumorzentrum, Forschungsgruppenleiter Tumorimmuntherapie, DBM und DKF 

Show profile

5c815f38-548f-470f-81aa-024ed3906592

Prof. Alfred Zippelius

Co-Chefarzt

Medizinische Onkologie FMH, Mitglied Tumorzentrum, Leiter Labor Tumorimmunologie

Show profile

Team

f1598dff-4bc7-4990-a387-45a46f50c37d

Prof. Emanuel Christ

Leitender Arzt

Endokrinologie, Diabetologie & Metabolismus

Show profile

cb8f669b-928d-4e43-bfab-6ce8799c8380

Prof. Jörg Halter

Leitender Arzt

Hämatologie

Show profile

a1d759be-d704-4a83-981c-a6151845c1d4

Dr. Kathleen Jahn

Kaderärztin, ärztliche Leitung interventionelle Pneumologie

Pneumologie

Show profile

afa3309a-6fbc-45cd-bdd5-6526a34e8412

Prof. Gabriela Kuster Pfister

Kaderärztin

Kardiologie

Show profile

2db28b00-68a3-43bd-b222-036432230649

Prof. Matthias Mehling

Leitender Arzt

Neurologie

Show profile

1d0c37b3-247b-4f4b-ba93-9fd8ea4f4060

Prof. Jan Hendrik Niess

Leitender Arzt Gastroenterologie/Hepatologie

Clarunis

Show profile

4bfad340-66b2-4def-8cd5-d7a0b7c5750d

Prof. Jürg Steiger

Ärztlicher Direktor

Medizinische Direktion

Show profile

Since September 2015, the Molecular Tumor Board has been the first of its kind in Switzerland to take place every two weeks. Treatment decisions are made here based on the genomic sequencing of tumors. The sequencing data is interpreted by molecular pathologists, biologists and medical geneticists, and treatment decisions are made together with medical oncologists and haematologists.

The well-established tumor board discusses patient findings from various specialist disciplines. For example, benign diseases from rheumatology are also discussed in order to utilize the interdisciplinarity of the board.

PD Dr. med. Dr. phil. Sacha Rothschild
Thursday: 2.30 - 4.30 pm

Registration
University Hospital Basel
Clinic for Oncology
Petersgraben 4
4031 Basel

Phone +41 61 265 50 74 and +41 61 265 50 59
onkologie@usb.ch

Management

c3588322-d2e9-46e9-a181-5ddf5e13729c

PD Dr. Benjamin Kasenda

Leitender Arzt

Innere Medizin Hämatologie/Onkologie und FA medizinische Onkologie

Gastrointestinale Tumore

Show profile

Members

Häuptle, Pirmin

Dr. Pirmin Häuptle

Show profile

bb924b4a-9125-45b9-a9de-318ae8ce518d

Prof. Dr. med. Dr. phil. nat. Karl Heinimann

Stv. Ärztlicher Leiter

Medizinische Genetik

Show profile

26f7d945-789d-4e95-ac3a-eb8d37925b50

Prof. Matthias Matter

Leitender Arzt und Fachbereichsleiter Molekularpathologie

Pathologie

Show profile

Mertz, Kirsten

PD Dr. Kirsten Mertz

Show profile